In a groundbreaking announcement, Russia has revealed that it has developed an mRNA-based cancer vaccine, which is set to be available to patients starting in early 2025.
In a groundbreaking announcement, Russia has revealed that it has developed an mRNA-based cancer vaccine, which is set to be available to patients starting in early 2025.
